Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2019 Mar 6

PMID 30834265

Citations 8

Authors

Yumei Huang

Rongrong Liu

Xiaoyun Wei

Jiaodi Liu

Lingyuan Pan

Gaohui Yang

Yongrong Lai

Affiliations

Soon will be listed here.

Abstract

Background: Extramedullary hematopoiesis (EMH) is common in non-transfusion-dependent thalassemia (NTDT) patients. Clinical presentations of EMH vary as MRI screening is not feasible. Hence, serum biomarkers are used to predict the risk of EMH.

Materials And Methods: 52 NTDT patients, including 26 EMH (+) and 26 EMH (-), together with 26 healthy controls, were enrolled in this case-control study from 2013 to 2016. EMH was confirmed by computed tomography or MRI. Demographic, transfusion, genetic, laboratory, and liver iron concentration (LIC) data, as well as clinical complications, were analyzed.

Results: EMH (+) patients had significantly higher serum ferritin (SF), growth differentiation factor 15 (GDF15), and erythropoietin (EPO) levels compared with EMH (-) patients and controls. The levels of erythroferrone (ERFE), hepcidin, and sTfR did not differ significantly between EMH (+) and EMH (-) patients (p>0.05). In NTDT patients, serum ERFE was not related to SF, LIC, hepcidin, sTfR, EPO, GDF15, and Hb levels. GDF15, EPO concentrations, and GDF15 to sTfR and GDF15 to EPO ratios are able to determine the presence of EMH with considerable sensitivity and specificity.

Conclusions: GDF15, EPO, and GDF15 to EPO and GDF15 to sTfR ratios are potential biomarkers for the early prediction of NTDT in patients who are at risk for EMH.

Citing Articles

A case of intrathoracic extramedullary hematopoiesis-associated pleural effusion in a beta-thalassemia intermedia patient and a short literature review.

Barakos G, Papazafiropoulou A, Mihos K, Eminidou V, Andronikou S, Ainalidou L SAGE Open Med Case Rep. 2024; 12:2050313X241305169.

PMID: 39634073 PMC: 11615976. DOI: 10.1177/2050313X241305169.

A randomized placebo-controlled clinical trial of oral green tea epigallocatechin 3-gallate on erythropoiesis and oxidative stress in transfusion-dependent β-thalassemia patients.

Settakorn K, Hantrakool S, Petiwathayakorn T, Hutachok N, Tantiworawit A, Charoenkwan P Front Mol Biosci. 2024; 10:1248742.

PMID: 38328786 PMC: 10848917. DOI: 10.3389/fmolb.2023.1248742.

Increased iron uptake by splenic hematopoietic stem cells promotes TET2-dependent erythroid regeneration.

Tseng Y, Kageyama Y, Murdaugh R, Kitano A, Kim J, Hoegenauer K Nat Commun. 2024; 15(1):538.

PMID: 38225226 PMC: 10789814. DOI: 10.1038/s41467-024-44718-0.

Extramedullary haematopoiesis in patients with thalassemia: a cross-sectional description of its prevalence, clinical features and survival.

Chapchap E, Silva M, Baroni R, Araujo A, de Assis R, Loggetto S Hematol Transfus Cell Ther. 2023; 46 Suppl 5:S143-S151.

PMID: 37690980 PMC: 11670632. DOI: 10.1016/j.htct.2023.07.005.

Phosphatidylserine-exposed red blood cells and ineffective erythropoiesis biomarkers in patients with thalassemia.

Chansai S, Yamsri S, Fucharoen S, Fucharoen G, Teawtrakul N Am J Transl Res. 2022; 14(7):4743-4756.

PMID: 35958503 PMC: 9360869.

References

Taher A, Ismaeel H, Cappellini M . Thalassemia intermedia: revisited. Blood Cells Mol Dis. 2006; 37(1):12-20. DOI: 10.1016/j.bcmd.2006.04.005. View

Tanno T, Bhanu N, Oneal P, Goh S, Staker P, Lee Y . High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med. 2007; 13(9):1096-101. DOI: 10.1038/nm1629. View

Tanno T, Porayette P, Sripichai O, Noh S, Byrnes C, Bhupatiraju A . Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood. 2009; 114(1):181-6. PMC: 2710947. DOI: 10.1182/blood-2008-12-195503. View

Theurl I, Finkenstedt A, Schroll A, Nairz M, Sonnweber T, Bellmann-Weiler R . Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia. Br J Haematol. 2009; 148(3):449-55. DOI: 10.1111/j.1365-2141.2009.07961.x. View

Taher A, Musallam K, Karimi M, El-Beshlawy A, Belhoul K, Daar S . Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2009; 115(10):1886-92. DOI: 10.1182/blood-2009-09-243154. View

Haidar R, Mhaidli H, Taher A . Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia. Eur Spine J. 2010; 19(6):871-8. PMC: 2899982. DOI: 10.1007/s00586-010-1357-2. View

Taher A, Musallam K, El-Beshlawy A, Karimi M, Daar S, Belhoul K . Age-related complications in treatment-naïve patients with thalassaemia intermedia. Br J Haematol. 2010; 150(4):486-9. DOI: 10.1111/j.1365-2141.2010.08220.x. View

Gardenghi S, Grady R, Rivella S . Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia. Hematol Oncol Clin North Am. 2010; 24(6):1089-107. PMC: 2991049. DOI: 10.1016/j.hoc.2010.08.003. View

Ginzburg Y, Rivella S . β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood. 2011; 118(16):4321-30. PMC: 3204905. DOI: 10.1182/blood-2011-03-283614. View

10.

Musallam K, Taher A, Duca L, Cesaretti C, Halawi R, Cappellini M . Levels of growth differentiation factor-15 are high and correlate with clinical severity in transfusion-independent patients with β thalassemia intermedia. Blood Cells Mol Dis. 2011; 47(4):232-4. DOI: 10.1016/j.bcmd.2011.07.005. View

11.

Ricchi P, Ammirabile M, Costantini S, Matola T, Verna R, Diano A . A useful relationship between the presence of extramedullary erythropoeisis and the level of the soluble form of the transferrin receptor in a large cohort of adult patients with thalassemia intermedia: a prospective study. Ann Hematol. 2011; 91(6):905-9. DOI: 10.1007/s00277-011-1385-y. View

12.

Belhoul K, Bakir M, Saned M, Kadhim A, Musallam K, Taher A . Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major. Ann Hematol. 2012; 91(7):1107-14. DOI: 10.1007/s00277-012-1412-7. View

13.

Musallam K, Rivella S, Vichinsky E, Rachmilewitz E . Non-transfusion-dependent thalassemias. Haematologica. 2013; 98(6):833-44. PMC: 3669437. DOI: 10.3324/haematol.2012.066845. View

14.

Ricchi P, Ammirabile M, Spasiano A, Costantini S, Matola T, Pepe A . Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia. Blood Transfus. 2013; 12 Suppl 1:s124-30. PMC: 3934250. DOI: 10.2450/2013.0287-12. View

15.

Yang G, Liu R, Peng P, Long L, Zhang X, Yang W . How early can myocardial iron overload occur in beta thalassemia major?. PLoS One. 2014; 9(1):e85379. PMC: 3899006. DOI: 10.1371/journal.pone.0085379. View

16.

Yotsumoto Fertrin K, Lanaro C, Fernanda Franco-Penteado C, de Albuquerque D, de Mello M, Pallis F . Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15. Am J Hematol. 2014; 89(4):385-90. DOI: 10.1002/ajh.23649. View

17.

Kautz L, Jung G, Valore E, Rivella S, Nemeth E, Ganz T . Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014; 46(7):678-84. PMC: 4104984. DOI: 10.1038/ng.2996. View

18.

Origa R, Cazzola M, Mereu E, Danjou F, Barella S, Giagu N . Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia. Haematologica. 2015; 100(5):e169-71. PMC: 4420223. DOI: 10.3324/haematol.2014.115733. View

19.

Tantawy A, Adly A, Rahman Ismail E, Youssef O, Ali M . Growth differentiation factor-15 in children and adolescents with thalassemia intermedia: Relation to subclinical atherosclerosis and pulmonary vasculopathy. Blood Cells Mol Dis. 2015; 55(2):144-50. DOI: 10.1016/j.bcmd.2015.06.001. View

20.

Ricchi P, Meloni A, Spasiano A, Neri M, Gamberini M, Cuccia L . Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients. Am J Hematol. 2015; 90(11):1008-12. DOI: 10.1002/ajh.24139. View